SecBot SecBot

Family Vaccine Protection Act

H.R. 3701 Rep. Frank Pallone (D-NJ-6) In committee
Bill text PDF
  1. Introduced Jun 4
  2. Committee Jun 4
  3. Passed House Next
  4. Passed Senate Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 4, 2025Next: House vote
511d ago Jun 4, 2025: Referred to the House Committee on Energy and Commerce.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Biotech & Pharma 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill amends the Public Health Service Act to codify the Advisory Committee on Immunization Practices (ACIP) into law and to modify the National Vaccine Injury Compensation Program. It establishes statutory requirements for ACIP's duties, membership, meetings, and decision-making processes, and requires that changes to the Vaccine Injury Table be supported by scientific evidence.

Sec. 2, Codification of ACIP: This section adds a new section 222A to the Public Health Service Act, formally establishing ACIP in statute. ACIP must base its advice and recommendations on a preponderance of the best available, peer-reviewed scientific evidence. The Director of the CDC must adopt ACIP recommendations unless they are not supported by such evidence, and must publish the basis for any rejection. ACIP must consider new vaccines within 90 days of licensure and make recommendations for breakthrough therapies and public health emergencies. If the Secretary or Director takes action contrary to an ACIP recommendation, they must publish the scientific basis and notify Congress within 48 hours. ACIP's duties include making immunization recommendations for group health plans and the Vaccines for Children Program. Membership is set at 15 to 19 voting members appointed by the Secretary from candidates recommended by the Comptroller General, with specific expertise requirements, plus 6 non-voting ex-officio members. Meetings must be held at least three times per year and within 90 days of a new vaccine's first marketing. The section authorizes $2,800,000 per year for fiscal years 2026 through 2029 for ACIP operations.

Sec. 3, National Vaccine Injury Compensation Program: This section amends the Vaccine Injury Table provisions to require that any removal of a vaccine from the table or any other modification, including additions to the list of compensable injuries, must be supported by a preponderance of the best available scientific evidence regarding the vaccine's safety or efficacy. It does not limit the Secretary's authority to add new vaccines to the table.

Summary of the bill text as introduced in House (Jun 4, 2025), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.